Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-010596

BIOMARIN PHARMACEUTICAL INC · BMRN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Robert Baffi
Officer — EVP, Technical Operations
Period of report
Mar 3, 2015
Accepted (ET)
Mar 5, 2015 · 8:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 3, 2015A10,500$0.00A109,700D
Common StockMar 5, 2015M11,000$17.86A120,700D
Common StockMar 5, 2015M3,051$14.39A123,751D
Common StockF2Mar 5, 2015S14,051$116.3683D109,700D
Common Stockholding———23,935IShares held by Baffi Family Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy) Common StockF3$108.36Mar 3, 2015A23,900ASep 3, 2015Mar 2, 2025Common Stock23,90023,900D
Stock Option (right to buy) Common StockF5,F4$17.86Mar 5, 2015M11,000DJun 17, 2009Dec 16, 2018Common Stock11,0000D
Stock Option (right to buy) Common StockF5,F6$14.39Mar 5, 2015M3,051DNov 12, 2009May 11, 2019Common Stock3,0510D

Explanation of responses